Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. More Details
No risks detected for SPI from our risk checks.
Moderate growth potential with imperfect balance sheet.
Share Price & News
How has Spire Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SPI is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SPI's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: SPI exceeded the UK Healthcare industry which returned 59.2% over the past year.
Return vs Market: SPI exceeded the UK Market which returned 27.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Spire Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWe Discuss Why Spire Healthcare Group plc's (LON:SPI) CEO Compensation May Be Closely Reviewed
1 month ago | Simply Wall StSpire Healthcare Group plc (LON:SPI) Shares Could Be 30% Below Their Intrinsic Value Estimate
1 month ago | Simply Wall StIs Spire Healthcare Group's (LON:SPI) 120% Share Price Increase Well Justified?
Is Spire Healthcare Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: SPI (£1.93) is trading above our estimate of fair value (£1.62)
Significantly Below Fair Value: SPI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SPI is unprofitable, so we can't compare its PE Ratio to the UK Healthcare industry average.
PE vs Market: SPI is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SPI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SPI is good value based on its PB Ratio (1.1x) compared to the GB Healthcare industry average (2.1x).
How is Spire Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SPI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: SPI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SPI's is expected to become profitable in the next 3 years.
Revenue vs Market: SPI's revenue (5.2% per year) is forecast to grow slower than the UK market (5.3% per year).
High Growth Revenue: SPI's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SPI's Return on Equity is forecast to be low in 3 years time (4.5%).
How has Spire Healthcare Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SPI is currently unprofitable.
Growing Profit Margin: SPI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SPI is unprofitable, and losses have increased over the past 5 years at a rate of 84.5% per year.
Accelerating Growth: Unable to compare SPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (1.3%).
Return on Equity
High ROE: SPI has a negative Return on Equity (-33.1%), as it is currently unprofitable.
How is Spire Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: SPI's short term assets (£250.1M) do not cover its short term liabilities (£253.9M).
Long Term Liabilities: SPI's short term assets (£250.1M) do not cover its long term liabilities (£1.1B).
Debt to Equity History and Analysis
Debt Level: SPI's debt to equity ratio (60.1%) is considered high.
Reducing Debt: SPI's debt to equity ratio has increased from 42.4% to 60.1% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SPI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SPI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 28.4% per year.
What is Spire Healthcare Group current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SPI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: SPI is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SPI's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Justin J. Ash, BA (Hons), has been the Chief Executive Officer and Executive Director of Spire Healthcare Group Plc since October 30, 2017. Mr. Ash served as the Chief Executive Officer at Oasis Health...
CEO Compensation Analysis
Compensation vs Market: Justin's total compensation ($USD1.66M) is above average for companies of similar size in the UK market ($USD955.48K).
Compensation vs Earnings: Justin's compensation has increased whilst the company is unprofitable.
Experienced Management: SPI's management team is considered experienced (2.6 years average tenure).
Experienced Board: SPI's board of directors are considered experienced (3.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Spire Healthcare Group plc's company bio, employee growth, exchange listings and data sources
- Name: Spire Healthcare Group plc
- Ticker: SPI
- Exchange: LSE
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: UK£772.026m
- Shares outstanding: 400.84m
- Website: https://www.spirehealthcare.com
Number of Employees
- Spire Healthcare Group plc
- 3 Dorset Rise
- Greater London
- EC4Y 8EN
- United Kingdom
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It offers various treatments in the areas of allergy and infectious diseas...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/17 00:48|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.